HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sonia Partap Selected Research

N- (2- (4- (4- chlorophenyl)piperazin- 1- yl)ethyl)- 3- methoxybenzamide (PB 12)

11/2013Relapse patterns in pediatric embryonal central nervous system tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sonia Partap Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 12/2007
7Medulloblastoma
01/2021 - 11/2012
4Brain Neoplasms (Brain Tumor)
01/2020 - 12/2007
3Glioma (Gliomas)
01/2022 - 05/2015
2Typical Teratoid Rhabdoid Tumor
06/2022 - 11/2012
2Diffuse Intrinsic Pontine Glioma
01/2022 - 01/2018
2Carcinogenesis
12/2020 - 09/2011
2Central Nervous System Neoplasms
12/2019 - 03/2012
2Ependymoma
10/2019 - 10/2016
2Autistic Disorder (Autism)
10/2018 - 01/2015
2Migraine Disorders (Migraine)
03/2012 - 04/2006
1Craniopharyngioma (Craniopharyngiomas)
11/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Leukoencephalopathies
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019
1Avian Reticuloendotheliosis
10/2019
1Anaphylaxis (Anaphylactic Shock)
01/2018
1Hypoxia (Hypoxemia)
06/2015
1Hemorrhagic Cystitis
11/2012
1Primitive Neuroectodermal Tumors (PNET)
11/2012
1Stroke (Strokes)
03/2012
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2012
1Vascular System Injuries
03/2012
1Congenital Abnormalities (Deformity)
09/2011
1Birth Weight (Birth Weights)
09/2011
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
07/2011
1Infarction (Infarctions)
01/2011
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2011
1Seizures (Absence Seizure)
02/2009
1Lymphoma (Lymphomas)
12/2006
1Glioblastoma (Glioblastoma Multiforme)
10/2006

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2015 - 09/2011
2dipinacoline glutamateIBA
01/2022 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2019
2Arginine Vasopressin (Argipressin)IBA
10/2018 - 01/2015
1MLN 8237IBA
06/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1tyrosyltyrosine (Tyr-Tyr)IBA
01/2021
1Biological ProductsIBA
01/2021
1InterferonsIBA
11/2020
1ProteomeIBA
01/2020
1NeuropeptidesIBA
10/2018
1Vasopressins (Vasopressin)IBA
10/2018
1cabazitaxelFDA Link
01/2018
1HhAntag691IBA
09/2017
1CobaltIBA
06/2015
1GlycosaminoglycansIBA
06/2015
1IonsIBA
06/2015
1Oxygen (Dioxygen)IBA
06/2015
1Transcription Factors (Transcription Factor)IBA
06/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2015
1CollagenIBA
06/2015
1Bevacizumab (Avastin)FDA Link
05/2015
1N- (2- (4- (4- chlorophenyl)piperazin- 1- yl)ethyl)- 3- methoxybenzamide (PB 12)IBA
11/2013
1HemosiderinIBA
11/2013
1FHDIBA
11/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2012
1Etoposide (VP 16)FDA LinkGeneric
11/2012
1Alkylating AgentsIBA
11/2012
1ORALIT (ORS)IBA
09/2011
1Cytarabine (Cytosar-U)FDA LinkGeneric
07/2011
1Pharmaceutical PreparationsIBA
07/2011
1Levetiracetam (Keppra)FDA LinkGeneric
02/2009
1EnzymesIBA
02/2009
1SteroidsIBA
12/2006
1Temozolomide (Temodar)FDA LinkGeneric
10/2006

Therapy/Procedure

10Therapeutics
01/2022 - 12/2007
6Radiotherapy
01/2021 - 03/2012
2Adjuvant Chemotherapy
01/2021 - 11/2012
2Drug Therapy (Chemotherapy)
12/2019 - 11/2012
1Craniospinal Irradiation
01/2021
1Consolidation Chemotherapy
10/2019
1Maintenance Chemotherapy
10/2019
1Cranial Irradiation
04/2006